KT-253

Overview

KT-253 is a kind of treatment called an MDM2 inhibitor. KT-253 may work by inhibiting proteins that cancer cells use to bypass the immune system to grow uncontrolled. 

SparkCures ID 745
Generic Name KT-253
Treatment Classifications
  • MDM2 Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.